Hepatitis C virus faces new weapon

In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.

Cell biologist pinpoints how RNA viruses copy themselves

Nihal Altan-Bonnet, assistant professor of cell biology, Rutgers University in Newark, and her research team have made a significant new discovery about RNA (Ribonucleic acid) viruses and how they replicate themselves.

A Twist in the Genome Thwarts Hepatitis C

(PhysOrg.com) -- Viruses like Hepatitis C proliferate by tricking cellular machinery into manufacturing the parts for duplicate viral particles.

Creating an artificial protein shell to combat COVID-19

During the first COVID-19 wave, when Saumitra Das and colleagues were sequencing thousands of samples every day to check for SARS-CoV-2 variants as part of INSACOG, the Government of India's genome surveillance initiative, ...

page 4 from 8